GlassScriptPhysician profile
Eric R Manahan
NPI 1295785194
$62,159.30
in general payments reported to CMS, 2019-2025
19 companies · $6,542 in 2025
The $6,542 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $52.39 · 2021: $5,093 · 2022: $7,565 · 2023: $13K · 2024: $30K · 2025: $6,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Food and Beverage: $4,104 · Education: $4,000 · Honoraria: $2,150 · Travel and Lodging: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,681.75 |
| Food and Beverage | $4,104.31 |
| Education | $4,000.00 |
| Honoraria | $2,150.00 |
| Travel and Lodging | $953.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $21,022.56 | 2021-2025 | Precisetumor, Myrisk |
| Astrazeneca Pharmaceuticals LP | $18,124.50 | 2021-2024 | Lynparza |
| Endomagnetics LTD | $9,914.33 | 2019-2025 | Magseed, Magtrace, Sentimag |
| Intuitive Surgical, INC. | $4,701.42 | 2025 | |
| Astrazeneca Uk Limited | $3,490.50 | 2023 | |
| Elucent Medical | $3,020.95 | 2022-2025 | |
| Leica Microsystems INC. | $610.44 | 2019-2025 | Mammotome Elite, Mammotome Revolve |
| Molli Surgical (US) INC | $582.72 | 2022-2024 | |
| Hologic Sales and Service, LLC | $325.52 | 2025 | Sentimag, Magseed, Magtrace |
| Davol INC. | $230.77 | 2019-2025 | Arista |
| Depuy Synthes Sales INC. | $38.09 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $17.71 | 2019 | |
| Integra Lifesciences Corporation | $16.97 | 2024 | Integra, Surgimend, Omnigraft |
| Smith+Nephew, INC. | $13.63 | 2024 | Stravix |
| Abbvie INC. | $13.13 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $12.67 | 2021 | |
| Ethicon US, LLC | $11.87 | 2020 | |
| Boston Scientific Corporation | $11.52 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Manahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.